Texas A&M spin-off, Pulmotect, Inc., receives $3 million NIH grant to fund infection prevention drug trials
Clinical-stage biotechnology company Pulmotect, Inc., has been awarded a $3 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) to evaluate the safety and effectiveness of PUL-042, an inhaled therapeutic designed to prevent and treat respiratory infections in cancer patients with compromised immune systems.
The Texas A&M University System Board of Regents has officially approved establishment of the Texas A&M Center for Epigenetics and Disease Prevention as an organizational unit under the Texas A&M Health Science Center Institute of Biosciences and Technology. The formal recognition will play a large role in the two-year-old center’s future growth as it aims to develop treatments using naturally occurring compounds to prevent and manage diseases.
Cheryl Lyn Walker, Ph.D., Welch Chair of Chemistry and director of the Texas A&M Institute of Biosciences and Technology, was recently named Outstanding Distinguished Scientist for 2015 by the Texas A&M University Chapter of Sigma Xi. The coveted award is bestowed upon one scientist each year who exhibits exemplary accomplishments in science and engineering.
Texas A&M Institute of Biosciences and Technology joins Gulf Coast Consortia, further propels team science across Texas Medical Center
The Texas A&M Health Science Center Institute of Biosciences and Technology in Houston has been named the newest member of the Gulf Coast Consortia, a Houston-Galveston area organization and one of the largest inter-institutional academic cooperatives in the nation focused on building strong, collaborative, biomedical research groups and interdisciplinary training opportunities for students.
Acknowledging the integral function of academia in the advancement of cancer research and prevention efforts across the state, the University Advisory Committee (UAC) of the Cancer Prevention and Research Institute of Texas (CPRIT) voted Cheryl Lyn Walker, Ph.D., director of the Texas A&M Health Science Center Institute of Biosciences and Technology (IBT), as chair of UAC.